KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Non-Current Deferred Tax Liability: 2010-2024

Historic Non-Current Deferred Tax Liability for Charles River Laboratories International (CRL) over the last 12 years, with Dec 2024 value amounting to $107.0 million.

  • Charles River Laboratories International's Non-Current Deferred Tax Liability fell 26.67% to $123.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $123.0 million, marking a year-over-year decrease of 26.67%. This contributed to the annual value of $107.0 million for FY2024, which is 75.77% down from last year.
  • Latest data reveals that Charles River Laboratories International reported Non-Current Deferred Tax Liability of $107.0 million as of FY2024, which was down 75.77% from $441.4 million recorded in FY2023.
  • Charles River Laboratories International's 5-year Non-Current Deferred Tax Liability high stood at $441.4 million for FY2023, and its period low was $107.0 million during FY2024.
  • Over the past 3 years, Charles River Laboratories International's median Non-Current Deferred Tax Liability value was $433.1 million (recorded in 2022), while the average stood at $327.1 million.
  • As far as peak fluctuations go, Charles River Laboratories International's Non-Current Deferred Tax Liability increased by 26.66% in 2020, and later plummeted by 75.77% in 2024.
  • Charles River Laboratories International's Non-Current Deferred Tax Liability (Yearly) stood at $348.5 million in 2020, then rose by 20.67% to $420.6 million in 2021, then climbed by 2.97% to $433.1 million in 2022, then rose by 1.92% to $441.4 million in 2023, then slumped by 75.77% to $107.0 million in 2024.